Allergy and Immunology · San Diego, CA
NPI
1285654889
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8899 University Center Ln Ste 230
San Diego, CA, 92122
Phone (858) 657-5350
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
866 services
Medicare patients, 2024
160
Average age 70
Drug cost, 2024
$15.2M
1,009 prescriptions
Company payments, 2025
$135K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc A Riedl was code 95004 (test - miscellaneous), 455 times for 13 patients. In total Marc A Riedl billed 866 services in 24 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 455 | 13 | $3.21 | $1,462 |
| 99215 Office E&M - Established | Office | 95 | 72 | $146.21 | $14K |
| 99214 Office E&M - Established | Office | 58 | 49 | $106.26 | $6,163 |
| 36415 Venipuncture Blood Collection | Office | 22 | 20 | $8.65 | $190 |
| 99205 Office E&M - New | Office | 19 | 19 | $184.46 | $3,505 |
| 99213 Office E&M - Established | Office | 18 | 15 | $77.57 | $1,396 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 15 | 14 | $26.72 | $401 |
By year: 2022 $29K for 1,071 services; 2023 $29K for 1,082 services; 2024 $31K for 866 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 22 | 20 | $8.65 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Marc A Riedl prescribed most often to Medicare patients was Takhzyro (Lanadelumab-Flyo), with 121 prescriptions and refills. In total Marc A Riedl wrote 1,009 Medicare prescriptions that cost $15.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Takhzyro Lanadelumab-Flyo | 121 | 121 | 13 | $5.9M |
| Icatibant Icatibant Acetate | 78 | 78 | 18 | $1.1M |
| Azelastine Hcl Generic | 69 | 85 | 18 | $2,390 |
| Montelukast Sodium Generic | 67 | 181 | 26 | $684 |
| Epinephrine Generic | 65 | 77 | 21 | $18K |
| Haegarda C1 Esterase Inhibitor | 47 | 47 | Under 11 | $1.8M |
| Dupixent Syringe Dupilumab | 44 | 45 | Under 11 | $157K |
| Cuvitru Immun Glob G(Igg)/Gly/Iga Ov50 | 40 | 40 | Under 11 | $285K |
| Firazyr Icatibant Acetate | 35 | 35 | Under 11 | $2.5M |
| Prednisone Generic | 30 | 30 | 20 | $40.3 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 28 | 28 | Under 11 | $201K |
| Cromolyn Sodium Generic | 27 | 39 | Under 11 | $20K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 26 | 26 | Under 11 | $266K |
| Berinert C1 Esterase Inhibitor | 26 | 26 | Under 11 | $2.2M |
| Fluticasone Propionate Generic | 23 | 41 | Under 11 | $204 |
Brand drugs: 515 claims; generic drugs: 494 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc A Riedl $135K ($100K in general payments such as food, travel and fees and $35K for research) from 14 companies. The largest payer was Novartis Pharmaceuticals Corporation with $40K.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 5 | $40K |
| CSL Behring CSL.AX | 23 | $38K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 15 | $17K |
| Pharming Healthcare, Inc. | 10 | $9,380 |
| Ionis Pharmaceuticals, Inc. IONS | 3 | $8,828 |
| Grifols USA, LLC | 5 | $8,168 |
| BioCryst Pharmaceuticals, Inc. BCRX | 13 | $8,013 |
| Theratechnologies Inc. THTX | 1 | $4,170 |
| BioCryst US Sales Co., LLC | 7 | $728 |
| Grifols Shared Services North America, Inc. | 1 | $713 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.